Drug intelligence / Profile preview

oxytropis falcata bunge

Development stage
Preclinical
Administration
Oral, Topical
01

Overview

Oxytropis falcata Bunge is a perennial, stemless herb traditionally used in Tibetan and Chinese medicine. It is widely recognized for its **anti-inflammatory**, **analgesic**, **antioxidant**, **antibacterial**, **hemostatic**, and **antitumor** properties. OF is used clinically for conditions such as **fever**, **pain**, **rheumatoid arthritis**, and **eczema**, and is an active component in formulations like Qingpeng Ointment and Qizheng Xiaotong plaster. Key pharmacologically active compounds are **flavonoids**, including isoflavones (e.g., daidzein, maackiain), flavones (e.g., 7-hydroxyflavone, luteolin), naringenin, and chalcones. Mechanistic studies show that extracts of this plant can inhibit proinflammatory cytokine release and downregulate pathways such as HDAC3/NF-κB and JAK1/STAT1, contributing to reduced inflammation and tissue injury in models of atopic dermatitis and pulmonary fibrosis. Additionally, it upregulates SOCS3, an inhibitor of cytokine signaling[1][2][4][5][7].

Other names
oxytropis falcatasickle-shaped oxytropisOFOFE
02

Targets

SOCS3 (Suppressor of cytokine signaling 3)JAK1 (Janus kinase 1)HDAC3 (Histone Deacetylase 3)STAT1 (Signal transducer and activator of transcription protein 1)NF-κB

Beyond the preview

Go deeper on oxytropis falcata bunge.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on oxytropis falcata bunge.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call